midazolam has been researched along with Cancer-Associated Pain in 5 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this small study in palliative cancer patients under real-life clinical conditions, the influence of CYP3A on fentanyl variability was investigated." | 2.90 | Minor contribution of cytochrome P450 3A activity on fentanyl exposure in palliative care cancer patients. ( Bardenheuer, HJ; Burhenne, J; Geist, MJP; Mikus, G; Skopp, G; Ziesenitz, VC, 2019) |
| "Delirium was the most frequent reason for PS (n = 15, 75%)." | 1.46 | Bispectral Index monitoring in cancer patients undergoing palliative sedation: a preliminary report. ( Allende-Pérez, S; Bruera, E; García-Salamanca, MF; Hui, D; Monreal-Carrillo, E; Verástegui, E, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geist, MJP | 1 |
| Ziesenitz, VC | 1 |
| Bardenheuer, HJ | 1 |
| Burhenne, J | 1 |
| Skopp, G | 1 |
| Mikus, G | 1 |
| Leiter, RE | 1 |
| Monreal-Carrillo, E | 1 |
| Allende-Pérez, S | 1 |
| Hui, D | 1 |
| García-Salamanca, MF | 1 |
| Bruera, E | 1 |
| Verástegui, E | 1 |
| Mercadante, S | 1 |
| Caruselli, A | 1 |
| Casuccio, A | 1 |
| Guo, CH | 1 |
| Bai, L | 1 |
| Wu, HH | 1 |
| Yang, J | 1 |
| Cai, GH | 1 |
| Zeng, SX | 1 |
| Wang, X | 1 |
| Wu, SX | 1 |
| Ma, W | 1 |
1 trial available for midazolam and Cancer-Associated Pain
| Article | Year |
|---|---|
Minor contribution of cytochrome P450 3A activity on fentanyl exposure in palliative care cancer patients.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Cytochrome P-450 CYP3A; Female; Fentanyl; | 2019 |
4 other studies available for midazolam and Cancer-Associated Pain
| Article | Year |
|---|---|
Ode to Joy.
Topics: Cancer Pain; Deep Sedation; Humans; Hypnotics and Sedatives; Male; Midazolam; Palliative Care; Termi | 2021 |
Bispectral Index monitoring in cancer patients undergoing palliative sedation: a preliminary report.
Topics: Adult; Aged; Awareness; Cancer Pain; Conscious Sedation; Consciousness; Delirium; Electroencephalogr | 2017 |
The use of ketamine in a palliative-supportive care unit: a retrospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Chemotherapy, Adjuvant; Female; Hum | 2018 |
Midazolam and ropivacaine act synergistically to inhibit bone cancer pain with different mechanisms in rats.
Topics: Amides; Anesthetics, Local; Animals; Bone Neoplasms; Cancer Pain; Drug Synergism; Drug Therapy, Comb | 2017 |